Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants-Reference-Cited by-同舟云学术

Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants

Published:2008-11-26 Issue:4 Volume:11 Page:381-393
ISSN:0969-6970
Container-title:Angiogenesis
language:en
Short-container-title:Angiogenesis

Author:

Morera Yanelys,Bequet-Romero Mónica,Ayala Marta,Lamdán Humberto,Agger Else-Marie,Andersen Peter,Gavilondo Jorge V.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Biochemistry,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10456-008-9121-5.pdf

Reference37 articles.

1. Folkman J (1985) Tumor angiogenesis. Adv Cancer Res 43:175–203

2. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273–286

3. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW (1991) The vascular endothelial growth factor family of polypeptides. J Cell Biochem 47:211–218

4. Dvorak HF (2002) Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 20:4368–4380

5. Ferrara N (2005) VEGF as a therapeutic target in cancer. Oncology 69(suppl 3):11–16

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in immunocompetent mouse tumor models;Cancer Letters;2023-05

2. Immune Deprivation of Growth Factors as Cancer Therapy;Handbook of Cancer and Immunology;2023

3. The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study;Archives of Cancer Science and Therapy;2022-09-20

4. Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF;Platelets;2022-04-03

5. VSSP abrogates murine ovarian tumor-associated myeloid cell-driven immune suppression and induces M1 polarization in tumor-associated macrophages from ovarian cancer patients;Cancer Immunology, Immunotherapy;2022-02-15